Evolution of Ulcerative Colitis Outcomes: Moving Beyond Endoscopic Remission Toward Histologic Endoscopic Mucosal Improvement

Evolution of Ulcerative Colitis Outcomes: Moving Beyond Endoscopic Remission Toward Histologic Endoscopic Mucosal Improvementa Faculty Miguel Regueiro, MD Chair, Department of Gastroenterology, Hepatology, and Nutrition Vice Chair, Digestive Disease and Surgery Institute Cleveland Clinic Cleveland, Ohio Ulcerative colitis (UC) is one of the major types of inflammatory bowel disease (IBD), with approxi.mately 1.3% of adults in the United States (an estimated 3 million people) diagnosed with IBD